Magnesium treatment for severe preeclampsia
Part of Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at different ways to give magnesium sulphate to women with severe preeclampsia to find the best treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with preeclampsia that has severe features
- Your doctor planned to give you magnesium sulphate
- Your medical records include details about which magnesium regimen you received
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study follows pregnant people with preeclampsia (a serious blood-pressure condition in pregnancy) to understand how it develops and affects both mother and baby. By participating, you help doctors learn more about this condition and potentially improve care for future patients.
This trial tests whether taking progesterone can improve outcomes for people with preeclampsia that is being managed without immediate delivery. It’s meant for pregnancies in a specific gestational age window and when both mother and baby are stable enough for “expectant management.”
This study tests whether giving magnesium sulphate (a mineral treatment) to pregnant women at risk of delivering very early (32–35 weeks) can protect the baby's brain and nervous system. The treatment is given before labor starts.
This study tests two different doses of magnesium sulfate to control seizures in overweight and obese women with preeclampsia. The goal is to find which dose works better and is safer for you and your baby.
This study looks at how biomarkers (specific substances in your blood) might help doctors better manage postpartum preeclampsia—high blood pressure and other symptoms that can appear after having a baby. You may qualify if you have severe preeclampsia during delivery or are receiving standard care after delivery.
This trial compares a common seizure medication (levetiracetam) with the standard drug (magnesium sulfate) to see which works better at preventing seizures in women with severe preeclampsia, a complication of pregnancy. If you are pregnant or have recently given birth and have severe preeclampsia or HELLP syndrome, you may be able to join.
Hear when a new Preeclampsia (PE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.